ArticleScientific reports2025
Atmospheric pressure plasma treatment increases the antioxidant capacity of the serum in vitro.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The interaction of atmospheric pressure plasma (APP) with the liquids has been fully studied, and multiple biomedical applications of APP-activated liquids have also been verified. However, there is still no direct evidence regarding the interaction between APP treatment and serum. In the present study, the rat serum was treated with the helium APP device. Compared with APP-treated saline, the elevation of reactive oxygen species (ROS) levels in serum was significantly smaller, implying that an antioxidant system existed in serum. The proteomics suggested that differently expressed proteins were predominantly enriched in the glutathione metabolism pathway. Our results showed that APP treatment significantly increased the serum GSH level and GSH/GSSG ratio, suggesting the enhanced antioxidant capacity of the APP-treated serum. Furthermore, the antioxidant enzymes in APP-treated serum were examined. As a result, both the glutathione peroxidase (GPX) protein level and enzyme activity were up-regulated according to the parallel reaction monitoring (PRM) analysis and GPX enzyme activity analysis. Meanwhile, the activities of glutathione reductase (GR) and superoxide dismutase (SOD) enzymes were also enhanced after APP treatment, while the catalase (CAT) activity decreased. Meanwhile, the total antioxidant capacity (T-AOC) also increased, as confirmed by the evidence of the superior ROS scavenging by APP-treated serum. Our data highlight that APP treatment can enhance the antioxidant capacity of the serum, which is closely related to the up-regulated GSH level, GSH/GSSG ratio and antioxidant enzymes within serum after APP treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.